IREB2 and neoplasm: The tumor growth inhibition (TGI) for IRP2 KO(−/−) #1 cell was 77%, and for IRP2 KO(−/−) #2 cell, it was 70% on day 44, with both results showing statistical significance (**p < 0.01) (Fig. 1C and D, and 1E).